Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Breast 3Head & Neck 2Gastrointestinal 2Thoracic 1Sarcoma 1Plasma cell 1Dermatologic 1

Conditions

Lung Neoplasms 2Vomiting 1Nausea 1Esophageal Neoplasms 1

Interventions

Dexamethasone 3Aprepitant 2Analgesia 2netupitant, palosentron drug combination 1netupitant 1fosaprepitant 1casopitant 1Yoga 1Therapeutics 1Radiotherapy 1Psychiatric Rehabilitation 1Palonosetron 1Ondansetron 1Massage 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nausea × Palonosetron × Thoracic × Clear all
NCT02445872 2015-12-09

Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy

Zhejiang University

Phase 2 Unknown
80 enrolled
Thoracic

Lung Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡